Dolby Family Ventures — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases.
AI & Machine LearningBiotechMedical DevicesNew York, US
Maria Pineda, PhD(CEO & Co-founder)Martin Akerman, PhD(CEO & Co-founder)Martin Akerman(Executive Officer, Director, Promoter)Maria Luisa Pineda(Executive Officer, Director, Promoter)Maria Luisa Pineda, PhD.(Founder)in
Co-investorsDynamk CapitalHAWKTAILM12 (Microsoft's Venture Fund)Madrona Venture GroupRed Cell IncubationThird Kind Venture Capital
Sepion develops advanced polymer separator technology for batteries and other applications including water separation and materials recovery.
CleantechDeep TechEnergyNew MaterialsSilicon Valley, US
Peter Frischmann(CEO & Co-Founder)inBrett Helms(CSO & Co-Founder)
BoardRandy Chan(Director)
Co-investorsACVC PartnersCreative VenturesFine Structures VenturesFoothill VenturesISVVoLo Earth Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.